L. Letranchant

1.1k total citations
15 papers, 70 citations indexed

About

L. Letranchant is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, L. Letranchant has authored 15 papers receiving a total of 70 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Applied Microbiology and Biotechnology. Recurrent topics in L. Letranchant's work include Antibiotic Use and Resistance (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Infective Endocarditis Diagnosis and Management (3 papers). L. Letranchant is often cited by papers focused on Antibiotic Use and Resistance (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Infective Endocarditis Diagnosis and Management (3 papers). L. Letranchant collaborates with scholars based in France. L. Letranchant's co-authors include Christian Rabaud, Hélène Jeulin, Véronique Venard, Thanh Doco‐Lecompte, Jean‐Pierre Carteaux, Christine Selton‐Suty, Corentine Alauzet, Xavier Duval, Philippe Scheid and Vincent Gendrin and has published in prestigious journals such as SHILAP Revista de lepidopterología, JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of Medical Virology.

In The Last Decade

L. Letranchant

15 papers receiving 69 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Letranchant France 5 52 24 23 13 10 15 70
Golubinka Boševska North Macedonia 6 58 1.1× 6 0.3× 18 0.8× 25 1.9× 9 0.9× 15 106
Aikaterini Masgala Greece 6 39 0.8× 12 0.5× 18 0.8× 18 1.4× 5 0.5× 14 113
Freddy Guevara Colombia 4 41 0.8× 23 1.0× 16 0.7× 13 1.0× 1 0.1× 16 93
Patricia Meza-Meneses Mexico 7 47 0.9× 6 0.3× 89 3.9× 8 0.6× 3 0.3× 12 125
Rozenn Esvan Italy 6 44 0.8× 58 2.4× 46 2.0× 3 0.2× 3 0.3× 16 110
Aarthi Chary United States 8 80 1.5× 68 2.8× 53 2.3× 24 1.8× 2 0.2× 15 163
David Vinuesa Spain 7 38 0.7× 6 0.3× 64 2.8× 5 0.4× 9 0.9× 12 132
İrem Akdemir Kalkan Türkiye 6 25 0.5× 16 0.7× 40 1.7× 3 0.2× 1 0.1× 34 97
Erika Asperges Italy 7 31 0.6× 5 0.2× 58 2.5× 4 0.3× 3 0.3× 20 110
Diana Mabayoje United Kingdom 4 28 0.5× 55 2.3× 37 1.6× 4 0.3× 4 0.4× 4 88

Countries citing papers authored by L. Letranchant

Since Specialization
Citations

This map shows the geographic impact of L. Letranchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Letranchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Letranchant more than expected).

Fields of papers citing papers by L. Letranchant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Letranchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Letranchant. The network helps show where L. Letranchant may publish in the future.

Co-authorship network of co-authors of L. Letranchant

This figure shows the co-authorship network connecting the top 25 collaborators of L. Letranchant. A scholar is included among the top collaborators of L. Letranchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Letranchant. L. Letranchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rival, Gilles, et al.. (2023). Post-traumatic stress among COVID-19 survivors: A descriptive study of hospitalized first-wave survivors. SHILAP Revista de lepidopterología. 59. 20–25. 1 indexed citations
2.
Letranchant, L., et al.. (2018). Étude des pratiques de prévention de la grippe nosocomiale selon la profession hospitalière. Médecine et Maladies Infectieuses. 48(4). S131–S131. 1 indexed citations
3.
Terrier, Benjamin, Dominique Costagliola, Sophie Prévôt, et al.. (2013). Characteristics of B-Cell Lymphomas in HIV/HCV-Coinfected Patients During the Combined Antiretroviral Therapy Era. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(2). 249–253. 6 indexed citations
4.
Doco‐Lecompte, Thanh, et al.. (2012). Relevance of fluoroquinolone use in a French teaching hospital. Médecine et Maladies Infectieuses. 42(12). 608–614. 1 indexed citations
5.
Gendrin, Vincent, et al.. (2011). Amélioration de la prescription des fluoroquinolones dans les infections urinaires. Revue de pertinence à deux tours. La Presse Médicale. 41(1). e10–e14. 4 indexed citations
6.
Letranchant, L., Anne Debourgogne, Thanh Doco‐Lecompte, et al.. (2011). Fatal Histoplasma capsulatum Mitral Endocarditis in a French Patient Treated for Rheumatoid Arthritis. Mycopathologia. 173(2-3). 183–186. 2 indexed citations
7.
Doco‐Lecompte, Thanh, Sandrine Hénard, Christine Burty, et al.. (2011). Relevance of fluoroquinolone use in hospitals in the Lorraine region of France before and after corrective measures: An investigation by the Antibiolor network. Scandinavian Journal of Infectious Diseases. 44(2). 86–92. 1 indexed citations
8.
Selton‐Suty, Christine, Thanh Doco‐Lecompte, Yvette Bernard, et al.. (2010). Clinical and Microbiologic Features of Multivalvular Endocarditis. Current Infectious Disease Reports. 12(4). 237–243. 14 indexed citations
9.
Hénard, Sandrine, L. Letranchant, F. Ajana, et al.. (2010). Étude des infections à VIH nouvellement découvertes entre 2000 et 2007 dans le Nord et l’Est de la France. Médecine et Maladies Infectieuses. 40(9). 517–523. 1 indexed citations
10.
Jeulin, Hélène, et al.. (2009). Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. Journal of Medical Virology. 82(2). 206–212. 24 indexed citations
11.
Doco‐Lecompte, Thanh, Philippe Scheid, P. Zück, et al.. (2009). Revue de pertinence des fluoroquinolones en Lorraine : résultats de la première évaluation. Médecine et Maladies Infectieuses. 40(2). 106–111. 8 indexed citations
12.
Selton‐Suty, Christine, François Alla, L. Letranchant, et al.. (2009). 073 CLINICAL AND MICROBIOLOGICAL FEATURES OF MULTIVALVULAR INFECTIVE ENDOCARDITIS. International Journal of Antimicrobial Agents. 33. S28–S28. 1 indexed citations
13.
Lagier, Jean‐Christophe, L. Letranchant, Christine Selton‐Suty, et al.. (2008). Bactériémies et endocardites àStaphylococcus aureus. Annales de Cardiologie et d Angéiologie. 57(2). 71–77. 4 indexed citations
14.
Letranchant, L., Christine Selton‐Suty, Nejla Aissa, et al.. (2008). E-09 Endocardite chez le toxicomane : une décision opératoire difficile. Médecine et Maladies Infectieuses. 38. S146–S147. 1 indexed citations
15.
Letranchant, L., M. Ruivard, Claire Dauphin, V. Chanet, & Philippe Parent. (2004). Endocardites non infectieuses : étude rétrospective (6 cas). La Revue de Médecine Interne. 26(3). 189–195. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Golubinka Boševska Breakdown of academic impact, for papers by Aikaterini Masgala Breakdown of academic impact, for papers by Freddy Guevara Breakdown of academic impact, for papers by Patricia Meza-Meneses Breakdown of academic impact, for papers by Rozenn Esvan Breakdown of academic impact, for papers by Aarthi Chary Breakdown of academic impact, for papers by David Vinuesa Breakdown of academic impact, for papers by İrem Akdemir Kalkan Breakdown of academic impact, for papers by Erika Asperges Breakdown of academic impact, for papers by Diana Mabayoje
Rankless by CCL
2026